# Ikonisys to acquire Hospitex International

Ikonisys SA has entered into an agreement to acquire 100% of Hospitex International, an Italian-based world leader in Thin Layer Cytology and Cancer Diagnostics. The acquisition aims to combine technologies and expand geographical reach.

- Type: Acquisition
- Announced: 2023-11-30
- Status: announced
- Products: cancer diagnostic solutions, thin layer cytology slides, automated slide preparation systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ikonisys](https://endata.com/companies/74094.md) (acquirer)
- [Hospitex International](https://endata.com/companies/74095.md) (target)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20231129839137/en/Ikonisys-to-Acquire-Hospitex-International-and-Become-an-Integrated-Cancer-Diagnostic-Leader), 2023-11-30: "Ikonisys SA today announces its entry into an agreement in order to acquire 100% of Hospitex International."
- [alikoscientific.com](https://alikoscientific.com/2023/11/30/ikonisys-acquires-hospitex-leads-cancer-diagnostics/), 2023-11-30: "Ikonisys SA today announces its entry into an agreement in order to acquire 100% of Hospitex International."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.